Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
16.16
-0.15 (-0.95%)
Jul 28, 2026, 4:00 PM EDT - Market closed
Rallybio Market Cap
Rallybio has a market cap or net worth of $85.59 million as of July 29, 2026. Its market cap has increased by 312.43% in one year.
Market Cap
85.59M
Enterprise Value
38.95M
1-Year Change
312.43%
Ranking
Category
Stock Price
$16.16
ChartMarket Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $85.59M, a decrease of -78.90%. That is a compound annual growth rate of -26.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 85.59M | 195.31% |
| Dec 31, 2025 | 28.98M | -27.23% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 90.37M |
| Pelthos Therapeutics | 90.09M |
| NeOnc Technologies Holdings | 88.95M |
| Kalaris Therapeutics | 88.75M |
| Heron Therapeutics | 86.27M |
| Verrica Pharmaceuticals | 86.24M |
| Alterity Therapeutics | 85.18M |
| Champions Oncology | 85.13M |